Clinical Trials List
Protocol Number1379‐0006
NCT Number(ClinicalTrials.gov Identfier)-
Completed
2020-02-01 - 2020-08-01
Phase I
Terminated1
-
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/24
Investigators and Locations
Principal Investigator
Chia-Chi Lin
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Chiun Hsu
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
30 participants
